Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan J Done

Showing results (31-40 of 82) with videos related to

Pageof 9
Sort By:
Breast Cancer Research and Treatment|June 28, 2012
¹¹¹In-Bn-DTPA-nimotuzumab with/without modification with nuclear translocation sequence (NLS) peptides: an Auger electron-emitting radioimmunotherapeutic agent for EGFR-positive and trastuzumab (Herceptin)-resistant breast cancerAisha Fasih, Humphrey Fonge, Zhongli Cai, et al.
Neoplasia (New York, N.Y.)|July 3, 2007
Genomic alterations in sporadic synchronous primary breast cancer using array and metaphase comparative genomic hybridizationArezou A Ghazani, Nona Arneson, Keisha Warren, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 21, 2009
Micro-SPECT/CT with 111In-DTPA-pertuzumab sensitively detects trastuzumab-mediated HER2 downregulation and tumor response in athymic mice bearing MDA-MB-361 human breast cancer xenograftsKristin McLarty, Bart Cornelissen, Zhongli Cai, et al.
Breast Cancer Research and Treatment|July 27, 2010
Amplification of the prolactin receptor gene in mammary lobular neoplasiaDanh Tran-Thanh, Nona C Arneson, Melania Pintilie, et al.
BMC Cancer|July 24, 2010
Troglitazone suppresses telomerase activity independently of PPARgamma in estrogen-receptor negative breast cancer cellsFariborz Rashid-Kolvear, Michael A S Taboski, Johnny Nguyen, et al.
Breast Cancer Research and Treatment|March 1, 2024
Primary MALT lymphoma of the breast: pathological and radiological characteristicsYukiko Shibahara, Jan M A Delabie, Supriya Kulkarni, et al.
Molecular Pharmaceutics|June 28, 2012
Role of antibody-mediated tumor targeting and route of administration in nanoparticle tumor accumulation in vivoNiladri Chattopadhyay, Humphrey Fonge, Zhongli Cai, et al.
BMC Cancer|June 18, 2011
Clinical relevance of DNA microarray analyses using archival formalin-fixed paraffin-embedded breast cancer specimensAl Muktafi Sadi, Dong-Yu Wang, Bruce J Youngson, et al.
Journal of the National Cancer Institute|June 25, 2019
Annual vs Biennial Screening: Diagnostic Accuracy Among Concurrent Cohorts Within the Ontario Breast Screening ProgramAnna M Chiarelli, Kristina M Blackmore, Lucia Mirea, et al.
Molecular Cancer Research : MCR|October 24, 2007
Abelson interactor protein-1 positively regulates breast cancer cell proliferation, migration, and invasionChunjie Wang, Roya Navab, Vladimir Iakovlev, et al.
Pageof 9

Showing results (31-40 of 82) with videos related to

Sort By:
Pageof 9
Breast Cancer Research and Treatment|June 28, 2012
¹¹¹In-Bn-DTPA-nimotuzumab with/without modification with nuclear translocation sequence (NLS) peptides: an Auger electron-emitting radioimmunotherapeutic agent for EGFR-positive and trastuzumab (Herceptin)-resistant breast cancerAisha Fasih, Humphrey Fonge, Zhongli Cai, et al.
Neoplasia (New York, N.Y.)|July 3, 2007
Genomic alterations in sporadic synchronous primary breast cancer using array and metaphase comparative genomic hybridizationArezou A Ghazani, Nona Arneson, Keisha Warren, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 21, 2009
Micro-SPECT/CT with 111In-DTPA-pertuzumab sensitively detects trastuzumab-mediated HER2 downregulation and tumor response in athymic mice bearing MDA-MB-361 human breast cancer xenograftsKristin McLarty, Bart Cornelissen, Zhongli Cai, et al.
Breast Cancer Research and Treatment|July 27, 2010
Amplification of the prolactin receptor gene in mammary lobular neoplasiaDanh Tran-Thanh, Nona C Arneson, Melania Pintilie, et al.
BMC Cancer|July 24, 2010
Troglitazone suppresses telomerase activity independently of PPARgamma in estrogen-receptor negative breast cancer cellsFariborz Rashid-Kolvear, Michael A S Taboski, Johnny Nguyen, et al.
Breast Cancer Research and Treatment|March 1, 2024
Primary MALT lymphoma of the breast: pathological and radiological characteristicsYukiko Shibahara, Jan M A Delabie, Supriya Kulkarni, et al.
Molecular Pharmaceutics|June 28, 2012
Role of antibody-mediated tumor targeting and route of administration in nanoparticle tumor accumulation in vivoNiladri Chattopadhyay, Humphrey Fonge, Zhongli Cai, et al.
BMC Cancer|June 18, 2011
Clinical relevance of DNA microarray analyses using archival formalin-fixed paraffin-embedded breast cancer specimensAl Muktafi Sadi, Dong-Yu Wang, Bruce J Youngson, et al.
Journal of the National Cancer Institute|June 25, 2019
Annual vs Biennial Screening: Diagnostic Accuracy Among Concurrent Cohorts Within the Ontario Breast Screening ProgramAnna M Chiarelli, Kristina M Blackmore, Lucia Mirea, et al.
Molecular Cancer Research : MCR|October 24, 2007
Abelson interactor protein-1 positively regulates breast cancer cell proliferation, migration, and invasionChunjie Wang, Roya Navab, Vladimir Iakovlev, et al.
Pageof 9